Fulgent Genetics Q3 2024 Adj. EPS $0.31 Beats $(0.15) Estimate, Sales $71.740M Beat $71.718M Estimate
Benzinga Newsdesk 1 year ago
EarningsEarnings BeatsNews
Fulgent Genetics (NASDAQ:FLGT) reported quarterly earnings of $0.31 per share which beat the analyst consensus estimate of $(0.15) by 306.67 percent. This is a 179.49 percent increase over losses of $(0.39) per share
Fulgent Genetics (NASDAQ:FLGT) reported quarterly earnings of $0.31 per share which beat the analyst consensus estimate of $(0.15) by 306.67 percent. This is a 179.49 percent increase over losses of $(0.39) per share from the same period last year. The company reported quarterly sales of $71.740 million which beat the analyst consensus estimate of $71.718 million by 0.03 percent. This is a 15.29 percent decrease over sales of $84.687 million the same period last year.